Unity Biotechnology (UBX) Stock Pops on Positive Study Data

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Unity Biotechnology (UBX) stock is gaining on Tuesday after the company released results from a Phase 2 clinical trial of UBX1325. The post Unity Biotechnology (UBX) Stock Pops on Positive Study Data appeared first on InvestorPlace . More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.